Lung Cancer: Targeted Therapy in 2025.

Descriptive analysis of durvalumab use in unresectable stage III non-small cell lung cancer in patients treated in Quebec's University teaching hospitals.

A multicriteria vulnerability index for equitable resource allocation in public health funding.

Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome.

Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors' response in non-small cell lung cancer: a multicenter cohort study.

NEF-Induced HIV-Associated Nephropathy Through HCK/LYN Tyrosine Kinases.

Descriptive Analysis of First-Line Non-Small Cell Lung Cancer Treatment with Pembrolizumab in Tumors Expressing PD-L1 ≥ 50% in Patients Treated in Quebec's University Teaching Hospitals (DALP-First Study).

General Anesthesia versus Sedation, Both with Hemodynamic Control, during Intraarterial Treatment for Stroke: The GASS Randomized Trial.

Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer.

HIV-1 Nef Induces Hck/Lyn-Dependent Expansion of Myeloid-Derived Suppressor Cells Associated with Elevated Interleukin-17/G-CSF Levels.

The revised Approved Instructional Resources score: An improved quality evaluation tool for online educational resources.

Pharmacokinetics of Tobramycin Administered at the Beginning of Intermittent Hemodialysis Session (ESRD Study).

[Is screening for lung cancer in high-risk subjects using low-dose CT scan effective in reducing mortality?].

Discovery of a putative blood-based protein signature associated with response to ALK tyrosine kinase inhibition.

Analysis of the Genomic Landscape in ALK+ NSCLC Patients Identifies Novel Aberrations Associated with Clinical Outcomes.